Exact Sciences to buy Genomic Health for $2.8 billion
Cancer diagnostics company Exact Sciences Corp said on Monday it will buy healthcare company Genomic Health Inc for about $2.8 billion to bolster its cancer...
Trial of strength at 2,000 meters altitude: Celtic wrestling in Austria
Every year around St. Jacob’s Day, men from Austria’s Salzburg region grapple with each other in a natural arena at the top of the Hundstein...
Companies using Facebook ‘Like’ button liable for data: EU court
Companies that embed Facebook’s “Like” button on their websites allowing users’ personal data to be transferred to the U.S. social network can be held liable...
UK plays Brexit hardball with ‘stubborn’ EU, pound falls to a two-year low
Sterling hit a two-year low on Monday as Prime Minister Boris Johnson’s government said it now assumed there would be a no-deal Brexit because a...
Russian opposition leader Navalny discharged from hospital
Russian opposition leader Alexei Navalny was discharged from a Moscow hospital on Monday where he was being treated for an unexplained health problem and returned...
Indonesia needs time to exhaust existing supplies before switch to low-sulphur fuel – transport ministry
Indonesia needs more time to comply with global rules requiring low-sulphur marine fuels, its transport ministry said on Monday, citing abundant supply of higher-sulphur fuel....
Fintechs at the gate: online brokers target affluent Brazilians
A new breed of digital brokers is taking on the handful of Brazilian lenders such as Itau Unibanco Holding SA and Banco Bradesco SA that...
Nigerian court adjourns bail hearing for leader of banned Shi’ite group
A Nigerian court on Monday adjourned a bail hearing for the leader of a banned local Shi’ite Muslim group until Aug. 5....
British PM Johnson tells EU: Ready to talk Brexit when you shift position
British Prime Minister Boris Johnson has told EU leaders he will sit down for Brexit talks when they indicate that they are ready to shift...
Mylan to combine with Pfizer’s off-patent medicines unit
Mylan NV said on Monday it would combine with Pfizer Inc’s off-patent branded and generic established medicines business to form a global generic drugmaker....